YearStart
int64 2.02k
2.02k
| YearEnd
int64 2.02k
2.02k
| LocationAbbr
stringclasses 55
values | LocationDesc
stringclasses 55
values | DataSource
stringclasses 14
values | Topic
stringclasses 19
values | Question
stringclasses 109
values | Response
float64 | DataValueUnit
stringclasses 8
values | DataValueType
stringclasses 12
values | DataValue
float64 0
2.93M
⌀ | DataValueAlt
float64 0
2.93M
⌀ | DataValueFootnoteSymbol
stringclasses 9
values | DataValueFootnote
stringclasses 9
values | LowConfidenceLimit
float64 0
1.43k
⌀ | HighConfidenceLimit
float64 0
1.49k
⌀ | StratificationCategory1
stringclasses 5
values | Stratification1
stringclasses 26
values | StratificationCategory2
float64 | Stratification2
float64 | StratificationCategory3
float64 | Stratification3
float64 | Geolocation
stringclasses 54
values | LocationID
int64 1
78
| TopicID
stringclasses 19
values | QuestionID
stringclasses 109
values | ResponseID
float64 | DataValueTypeID
stringclasses 12
values | StratificationCategoryID1
stringclasses 5
values | StratificationID1
stringclasses 26
values | StratificationCategoryID2
float64 | StratificationID2
float64 | StratificationCategoryID3
float64 | StratificationID3
float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,020
| 2,020
|
US
|
United States
|
BRFSS
|
Health Status
|
Recent activity limitation among adults
| null |
Number
|
Age-adjusted Mean
| 2.9
| 2.9
| null | null | 2.8
| 2.9
|
Sex
|
Female
| null | null | null | null | null | 59
|
HEA
|
HEA04
| null |
AGEADJMEAN
|
SEX
|
SEXF
| null | null | null | null |
2,015
| 2,019
|
AR
|
Arkansas
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 9,537
| 9,537
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-92.27449074299966 34.74865012400045)
| 5
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,015
| 2,019
|
CA
|
California
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 486
| 486
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-120.99999953799971 37.63864012300047)
| 6
|
CAN
|
CAN03
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,015
| 2,019
|
CO
|
Colorado
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 2,880
| 2,880
| null | null | null | null |
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-106.13361092099967 38.843840757000464)
| 8
|
CAN
|
CAN07
| null |
NMBR
|
RACE
|
HIS
| null | null | null | null |
2,015
| 2,019
|
GA
|
Georgia
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
Number
|
Number
| 519
| 519
| null | null | null | null |
Race/Ethnicity
|
White, non-Hispanic
| null | null | null | null |
POINT (-83.62758034599966 32.83968109300048)
| 13
|
CAN
|
CAN05
| null |
NMBR
|
RACE
|
WHT
| null | null | null | null |
2,015
| 2,019
|
KS
|
Kansas
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 8,102
| 8,102
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-98.20078122699965 38.34774030000045)
| 20
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,015
| 2,019
|
ME
|
Maine
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 9,238
| 9,238
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-68.98503133599962 45.254228894000505)
| 23
|
CAN
|
CAN07
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,015
| 2,019
|
NJ
|
New Jersey
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 5,587
| 5,587
| null | null | null | null |
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-74.27369128799967 40.13057004800049)
| 34
|
CAN
|
CAN07
| null |
NMBR
|
RACE
|
HIS
| null | null | null | null |
2,015
| 2,019
|
NY
|
New York
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 2,547
| 2,547
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-75.54397042699964 42.82700103200045)
| 36
|
CAN
|
CAN02
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,015
| 2,019
|
OR
|
Oregon
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 548
| 548
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-120.15503132599969 44.56744942400047)
| 41
|
CAN
|
CAN02
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,015
| 2,019
|
SD
|
South Dakota
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
per 100,000
|
Crude Rate
| 20.2
| 20.2
| null | null | 18.4
| 22.2
|
Overall
|
Overall
| null | null | null | null |
POINT (-100.3735306369997 44.353130053000484)
| 46
|
CAN
|
CAN05
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,015
| 2,019
|
TX
|
Texas
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
per 100,000
|
Crude Rate
| 2.9
| 2.9
| null | null | 2.8
| 3
|
Sex
|
Female
| null | null | null | null |
POINT (-99.42677020599967 31.827240407000488)
| 48
|
CAN
|
CAN03
| null |
CRDRATE
|
SEX
|
SEXF
| null | null | null | null |
2,015
| 2,019
|
US
|
United States
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined) mortality among all people, underlying cause
| null |
Number
|
Number
| 314,982
| 314,982
| null | null | null | null |
Sex
|
Male
| null | null | null | null | null | 59
|
CAN
|
CAN08
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,015
| 2,019
|
VT
|
Vermont
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
per 100,000
|
Crude Rate
| 23
| 23
| null | null | 20.7
| 25.5
|
Overall
|
Overall
| null | null | null | null |
POINT (-72.51764079099962 43.62538123900049)
| 50
|
CAN
|
CAN05
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,015
| 2,019
|
WV
|
West Virginia
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
per 100,000
|
Crude Rate
| 31.6
| 31.6
| null | null | 30
| 33.2
|
Sex
|
Female
| null | null | null | null |
POINT (-80.71264013499967 38.66551020200046)
| 54
|
CAN
|
CAN02
| null |
CRDRATE
|
SEX
|
SEXF
| null | null | null | null |
2,015
| 2,019
|
WI
|
Wisconsin
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
per 100,000
|
Age-adjusted Rate
| 444.6
| 444.6
| null | null | 441.4
| 447.8
|
Sex
|
Female
| null | null | null | null |
POINT (-89.81637074199966 44.39319117400049)
| 55
|
CAN
|
CAN07
| null |
AGEADJRATE
|
SEX
|
SEXF
| null | null | null | null |
2,020
| 2,020
|
ID
|
Idaho
|
NVSS
|
Diabetes
|
Diabetic ketoacidosis mortality among all people, underlying or contributing cause
| null |
Number
|
Number
| 25
| 25
| null | null | null | null |
Age
|
Age >=65
| null | null | null | null |
POINT (-114.3637300419997 43.682630005000476)
| 16
|
DIA
|
DIA04
| null |
NMBR
|
AGE
|
AGE65P
| null | null | null | null |
2,015
| 2,019
|
WY
|
Wyoming
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 66
| 66
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-108.10983035299967 43.23554134300048)
| 56
|
CAN
|
CAN02
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
AZ
|
Arizona
|
US Cancer DVT
|
Cancer
|
Lung and bronchial cancer mortality among all people, underlying cause
| null |
Number
|
Number
| 1,408
| 1,408
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
CAN
|
CAN04
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
CA
|
California
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 4,503
| 4,503
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-120.99999953799971 37.63864012300047)
| 6
|
CAN
|
CAN02
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
CA
|
California
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 484
| 484
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-120.99999953799971 37.63864012300047)
| 6
|
CAN
|
CAN03
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
DC
|
District of Columbia
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
Number
|
Number
| null | null |
~
|
Data suppressed; too few respondents or cases
| null | null |
Sex
|
Male
| null | null | null | null |
POINT (-77.036871 38.907192)
| 11
|
CAN
|
CAN03
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
DC
|
District of Columbia
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 1,479
| 1,479
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-77.036871 38.907192)
| 11
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
FL
|
Florida
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| null | null |
~
|
Data suppressed; too few respondents or cases
| null | null |
Sex
|
Male
| null | null | null | null |
POINT (-81.92896053899966 28.932040377000476)
| 12
|
CAN
|
CAN02
| null |
AGEADJRATE
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
HI
|
Hawaii
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 3,644
| 3,644
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-157.85774940299973 21.304850435000446)
| 15
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
IL
|
Illinois
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
Number
|
Number
| 1,231
| 1,231
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-88.99771017799969 40.48501028300046)
| 17
|
CAN
|
CAN05
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
IL
|
Illinois
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
per 100,000
|
Crude Rate
| 560.6
| 560.6
| null | null | 558
| 563.2
|
Sex
|
Male
| null | null | null | null |
POINT (-88.99771017799969 40.48501028300046)
| 17
|
CAN
|
CAN07
| null |
CRDRATE
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
IA
|
Iowa
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined) mortality among all people, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| 185.3
| 185.3
| null | null | 182.5
| 188.1
|
Sex
|
Male
| null | null | null | null |
POINT (-93.81649055599968 42.46940091300047)
| 19
|
CAN
|
CAN08
| null |
AGEADJRATE
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
KS
|
Kansas
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| 19.8
| 19.8
| null | null | 18.9
| 20.8
|
Overall
|
Overall
| null | null | null | null |
POINT (-98.20078122699965 38.34774030000045)
| 20
|
CAN
|
CAN02
| null |
AGEADJRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
KS
|
Kansas
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| 14.6
| 14.6
| null | null | 11.2
| 18.6
|
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-98.20078122699965 38.34774030000045)
| 20
|
CAN
|
CAN02
| null |
AGEADJRATE
|
RACE
|
HIS
| null | null | null | null |
2,016
| 2,020
|
ME
|
Maine
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 4,764
| 4,764
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-68.98503133599962 45.254228894000505)
| 23
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
MA
|
Massachusetts
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
per 100,000
|
Age-adjusted Rate
| 428.3
| 428.3
| null | null | 425.5
| 431.1
|
Sex
|
Female
| null | null | null | null |
POINT (-72.08269067499964 42.27687047000046)
| 25
|
CAN
|
CAN07
| null |
AGEADJRATE
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
MN
|
Minnesota
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| 1.2
| 1.2
| null | null | 1
| 1.4
|
Overall
|
Overall
| null | null | null | null |
POINT (-94.79420050299967 46.35564873600049)
| 27
|
CAN
|
CAN03
| null |
AGEADJRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
MS
|
Mississippi
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
per 100,000
|
Age-adjusted Rate
| 20
| 20
| null | null | 18.8
| 21.1
|
Race/Ethnicity
|
White, non-Hispanic
| null | null | null | null |
POINT (-89.53803082499968 32.745510099000455)
| 28
|
CAN
|
CAN02
| null |
AGEADJRATE
|
RACE
|
WHT
| null | null | null | null |
2,016
| 2,020
|
MS
|
Mississippi
|
US Cancer DVT
|
Cancer
|
Lung and bronchial cancer mortality among all people, underlying cause
| null |
Number
|
Number
| 1,833
| 1,833
| null | null | null | null |
Overall
|
Overall
| null | null | null | null |
POINT (-89.53803082499968 32.745510099000455)
| 28
|
CAN
|
CAN04
| null |
NMBR
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
NE
|
Nebraska
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 20
| 20
| null | null | null | null |
Race/Ethnicity
|
White, non-Hispanic
| null | null | null | null |
POINT (-99.36572062299967 41.6410409880005)
| 31
|
CAN
|
CAN03
| null |
NMBR
|
RACE
|
WHT
| null | null | null | null |
2,016
| 2,020
|
NH
|
New Hampshire
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
per 100,000
|
Crude Rate
| 622.4
| 622.4
| null | null | 614.1
| 630.9
|
Sex
|
Female
| null | null | null | null |
POINT (-71.50036091999965 43.65595011300047)
| 33
|
CAN
|
CAN07
| null |
CRDRATE
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
NM
|
New Mexico
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 4,697
| 4,697
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-106.24058098499967 34.52088095200048)
| 35
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
NC
|
North Carolina
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 30,211
| 30,211
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-79.15925046299964 35.466220975000454)
| 37
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
SC
|
South Carolina
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
per 100,000
|
Crude Rate
| 22.6
| 22.6
| null | null | 21.8
| 23.5
|
Overall
|
Overall
| null | null | null | null |
POINT (-81.04537120699968 33.998821303000454)
| 45
|
CAN
|
CAN05
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
SC
|
South Carolina
|
US Cancer DVT
|
Cancer
|
Prostate cancer mortality among all males, underlying cause
| null |
Number
|
Number
| 558
| 558
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-81.04537120699968 33.998821303000454)
| 45
|
CAN
|
CAN05
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
SD
|
South Dakota
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined) mortality among all people, underlying cause
| null |
Number
|
Number
| 7
| 7
| null | null | null | null |
Race/Ethnicity
|
Black, non-Hispanic
| null | null | null | null |
POINT (-100.3735306369997 44.353130053000484)
| 46
|
CAN
|
CAN08
| null |
NMBR
|
RACE
|
BLK
| null | null | null | null |
2,016
| 2,020
|
UT
|
Utah
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 6
| 6
| null | null | null | null |
Race/Ethnicity
|
Asian or Pacific Islander, non-Hispanic
| null | null | null | null |
POINT (-111.58713063499971 39.360700171000474)
| 49
|
CAN
|
CAN02
| null |
NMBR
|
RACE
|
API
| null | null | null | null |
2,016
| 2,020
|
VT
|
Vermont
|
US Cancer DVT
|
Cancer
|
Lung and bronchial cancer mortality among all people, underlying cause
| null |
Number
|
Number
| 158
| 158
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-72.51764079099962 43.62538123900049)
| 50
|
CAN
|
CAN04
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
WV
|
West Virginia
|
US Cancer DVT
|
Cancer
|
Breast cancer mortality among all females, underlying cause
| null |
Number
|
Number
| 286
| 286
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-80.71264013499967 38.66551020200046)
| 54
|
CAN
|
CAN02
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
WV
|
West Virginia
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
per 100,000
|
Crude Rate
| 697
| 697
| null | null | 689.3
| 704.8
|
Sex
|
Male
| null | null | null | null |
POINT (-80.71264013499967 38.66551020200046)
| 54
|
CAN
|
CAN07
| null |
CRDRATE
|
SEX
|
SEXM
| null | null | null | null |
2,016
| 2,020
|
WI
|
Wisconsin
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined), incidence
| null |
Number
|
Number
| 16,451
| 16,451
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-89.81637074199966 44.39319117400049)
| 55
|
CAN
|
CAN07
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
WY
|
Wyoming
|
US Cancer DVT
|
Cancer
|
Colon and rectum (colorectal) cancer mortality among all people, underlying cause
| null |
per 100,000
|
Crude Rate
| 15
| 15
| null | null | 13.6
| 16.4
|
Overall
|
Overall
| null | null | null | null |
POINT (-108.10983035299967 43.23554134300048)
| 56
|
CAN
|
CAN01
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
WY
|
Wyoming
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
per 100,000
|
Crude Rate
| 2.1
| 2.1
| null | null | 1.4
| 3
|
Overall
|
Overall
| null | null | null | null |
POINT (-108.10983035299967 43.23554134300048)
| 56
|
CAN
|
CAN03
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,016
| 2,020
|
WY
|
Wyoming
|
US Cancer DVT
|
Cancer
|
Cervical cancer mortality among all females, underlying cause
| null |
per 100,000
|
Crude Rate
| 2.1
| 2.1
| null | null | 1.4
| 3
|
Sex
|
Female
| null | null | null | null |
POINT (-108.10983035299967 43.23554134300048)
| 56
|
CAN
|
CAN03
| null |
CRDRATE
|
SEX
|
SEXF
| null | null | null | null |
2,016
| 2,020
|
WY
|
Wyoming
|
US Cancer DVT
|
Cancer
|
Invasive cancer (all sites combined) mortality among all people, underlying cause
| null |
Number
|
Number
| 542
| 542
| null | null | null | null |
Sex
|
Male
| null | null | null | null |
POINT (-108.10983035299967 43.23554134300048)
| 56
|
CAN
|
CAN08
| null |
NMBR
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
AL
|
Alabama
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 40.9
| 40.9
| null | null | 34.4
| 47.7
|
Sex
|
Female
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,020
| 2,020
|
KY
|
Kentucky
|
BRFSS
|
Immunization
|
Influenza vaccination among adults
| null |
%
|
Crude Prevalence
| 41.6
| 41.6
| null | null | 33
| 50.7
|
Race/Ethnicity
|
Black, non-Hispanic
| null | null | null | null |
POINT (-84.77497104799966 37.645970271000465)
| 21
|
IMM
|
IMM01
| null |
CRDPREV
|
RACE
|
BLK
| null | null | null | null |
2,018
| 2,019
|
ID
|
Idaho
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 27.3
| 27.3
| null | null | 22.2
| 33.1
|
Sex
|
Male
| null | null | null | null |
POINT (-114.3637300419997 43.682630005000476)
| 16
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
KS
|
Kansas
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 34.2
| 34.2
| null | null | 28.3
| 40.6
|
Sex
|
Male
| null | null | null | null |
POINT (-98.20078122699965 38.34774030000045)
| 20
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
MD
|
Maryland
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 41.6
| 41.6
| null | null | 35.5
| 48.1
|
Sex
|
Female
| null | null | null | null |
POINT (-76.60926011099963 39.29058096400047)
| 24
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,018
| 2,019
|
MN
|
Minnesota
|
NSCH
|
Nutrition, Physical Activity, and Weight Status
|
Children and adolescents aged 6-13 years meeting aerobic physical activity guideline
| null |
%
|
Crude Prevalence
| 36.4
| 36.4
| null | null | 29
| 44.6
|
Sex
|
Male
| null | null | null | null |
POINT (-94.79420050299967 46.35564873600049)
| 27
|
NPAW
|
NPW07
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
MO
|
Missouri
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 31.7
| 31.7
| null | null | 27
| 36.7
|
Age
|
Age 6-14
| null | null | null | null |
POINT (-92.56630005299968 38.635790776000476)
| 29
|
SLEP
|
SLP01
| null |
CRDPREV
|
AGE
|
AGE6_14
| null | null | null | null |
2,018
| 2,019
|
MT
|
Montana
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 26
| 26
| null | null | 20.8
| 32
|
Sex
|
Female
| null | null | null | null |
POINT (-109.42442064499971 47.06652897200047)
| 30
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,018
| 2,019
|
NV
|
Nevada
|
NSCH
|
Nutrition, Physical Activity, and Weight Status
|
Children and adolescents aged 6-13 years meeting aerobic physical activity guideline
| null |
%
|
Crude Prevalence
| 17.2
| 17.2
| null | null | 12
| 24.1
|
Sex
|
Male
| null | null | null | null |
POINT (-117.07184056399967 39.493240390000494)
| 32
|
NPAW
|
NPW07
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
ND
|
North Dakota
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 25.5
| 25.5
| null | null | 20.3
| 31.5
|
Sex
|
Female
| null | null | null | null |
POINT (-100.11842104899966 47.47531977900047)
| 38
|
SLEP
|
SLP01
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,018
| 2,019
|
US
|
United States
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 34.4
| 34.4
| null | null | 33.5
| 35.4
|
Overall
|
Overall
| null | null | null | null | null | 59
|
SLEP
|
SLP01
| null |
CRDPREV
|
OVERALL
|
OVR
| null | null | null | null |
2,018
| 2,019
|
UT
|
Utah
|
NSCH
|
Oral Health
|
Receipt of evidence-based preventive dental services in the past 12 months among children and adolescents aged 1-17 years
| null |
%
|
Crude Prevalence
| 62.7
| 62.7
| null | null | 56.2
| 68.8
|
Age
|
Age 12-17
| null | null | null | null |
POINT (-111.58713063499971 39.360700171000474)
| 49
|
ORH
|
ORH05
| null |
CRDPREV
|
AGE
|
AGE1217
| null | null | null | null |
2,018
| 2,019
|
VI
|
Virgin Islands
|
NSCH
|
Oral Health
|
Receipt of evidence-based preventive dental services in the past 12 months among children and adolescents aged 1-17 years
| null |
%
|
Crude Prevalence
| null | null |
*
|
No data available
| null | null |
Sex
|
Male
| null | null | null | null |
POINT (-64.896335 18.335765)
| 78
|
ORH
|
ORH05
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,018
| 2,019
|
WV
|
West Virginia
|
NSCH
|
Sleep
|
Short sleep duration among children aged 4 months to 14 years
| null |
%
|
Crude Prevalence
| 45.5
| 45.5
| null | null | 38.5
| 52.7
|
Age
|
Age 4 m - 5 y
| null | null | null | null |
POINT (-80.71264013499967 38.66551020200046)
| 54
|
SLEP
|
SLP01
| null |
CRDPREV
|
AGE
|
AGE4M5Y
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Arthritis
|
Arthritis among adults
| null |
%
|
Crude Prevalence
| 29.9
| 29.9
| null | null | 27.9
| 32
|
Sex
|
Male
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
ART
|
ART01
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Asthma
|
Current asthma among adults
| null |
%
|
Crude Prevalence
| 8.1
| 8.1
| null | null | 6.7
| 9.7
|
Sex
|
Male
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
AST
|
AST02
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Cardiovascular Disease
|
Taking medicine to control high blood pressure among adults with high blood pressure
| null |
%
|
Crude Prevalence
| 85.2
| 85.2
| null | null | 82.8
| 87.4
|
Sex
|
Female
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
CVD
|
CVD02
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
NVSS
|
Cardiovascular Disease
|
Coronary heart disease mortality among all people, underlying cause
| null |
Number
|
Number
| 2,003
| 2,003
| null | null | null | null |
Sex
|
Female
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
CVD
|
CVD08
| null |
NMBR
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Disability
|
Adults with any disability
| null |
%
|
Crude Prevalence
| 35.1
| 35.1
| null | null | 33.3
| 36.9
|
Race/Ethnicity
|
White, non-Hispanic
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
DIS
|
DIS01
| null |
CRDPREV
|
RACE
|
WHT
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Mental Health
|
Frequent mental distress among adults
| null |
%
|
Crude Prevalence
| 21
| 21
| null | null | 18.7
| 23.6
|
Age
|
Age 18-44
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
MEN
|
MEN05
| null |
CRDPREV
|
AGE
|
AGE1844
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
YRBSS
|
Sleep
|
Short sleep duration among high school students
| null |
%
|
Crude Prevalence
| 80
| 80
| null | null | 75.4
| 84
|
Grade
|
Grade 12
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
SLEP
|
SLP02
| null |
CRDPREV
|
GRADE
|
GRD12
| null | null | null | null |
2,019
| 2,019
|
AL
|
Alabama
|
BRFSS
|
Tobacco
|
Quit attempts in the past year among adult current smokers
| null |
%
|
Crude Prevalence
| null | null |
*
|
No data available
| null | null |
Race/Ethnicity
|
Hawaiian or Pacific Islander, non-Hispanic
| null | null | null | null |
POINT (-86.63186076199969 32.84057112200048)
| 1
|
TOB
|
TOB06
| null |
CRDPREV
|
RACE
|
HAPI
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
BRFSS
|
Alcohol
|
Binge drinking prevalence among adults
| null |
%
|
Crude Prevalence
| 11.1
| 11.1
| null | null | 8.5
| 14.4
|
Sex
|
Female
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
ALC
|
ALC06
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
BRFSS
|
Asthma
|
Current asthma among adults
| null |
%
|
Age-adjusted Prevalence
| 13.3
| 13.3
| null | null | 10.6
| 16.5
|
Sex
|
Female
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
AST
|
AST02
| null |
AGEADJPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
NVSS
|
Chronic Obstructive Pulmonary Disease
|
Chronic obstructive pulmonary disease mortality among adults aged 45 years and older, underlying cause
| null |
cases per 100,000
|
Crude Rate
| 70
| 70
| null | null | 60
| 80
|
Overall
|
Overall
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
COPD
|
COPD05
| null |
CRDRATE
|
OVERALL
|
OVR
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
BRFSS
|
Disability
|
Adults with any disability
| null |
%
|
Age-adjusted Prevalence
| 25.5
| 25.5
| null | null | 21.9
| 29.4
|
Sex
|
Female
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
DIS
|
DIS01
| null |
AGEADJPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
BRFSS
|
Health Status
|
Frequent physical distress among adults
| null |
%
|
Crude Prevalence
| 13.4
| 13.4
| null | null | 10.6
| 16.7
|
Age
|
Age 45-64
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
HEA
|
HEA03
| null |
CRDPREV
|
AGE
|
AGE4564
| null | null | null | null |
2,019
| 2,019
|
AK
|
Alaska
|
BRFSS
|
Nutrition, Physical Activity, and Weight Status
|
Obesity among adults
| null |
%
|
Crude Prevalence
| 26.9
| 26.9
| null | null | 22.7
| 31.6
|
Age
|
Age 18-44
| null | null | null | null |
POINT (-147.72205903599973 64.84507995700051)
| 2
|
NPAW
|
NPW14
| null |
CRDPREV
|
AGE
|
AGE1844
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
BRFSS
|
Alcohol
|
Binge drinking prevalence among adults
| null |
%
|
Crude Prevalence
| 20.9
| 20.9
| null | null | 18.4
| 23.6
|
Age
|
Age 18-44
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
ALC
|
ALC06
| null |
CRDPREV
|
AGE
|
AGE1844
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
BRFSS
|
Arthritis
|
Arthritis among adults
| null |
%
|
Age-adjusted Prevalence
| 28.4
| 28.4
| null | null | 21.9
| 36
|
Race/Ethnicity
|
Black, non-Hispanic
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
ART
|
ART01
| null |
AGEADJPREV
|
RACE
|
BLK
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
BRFSS
|
Arthritis
|
Received health care provider counseling for physical activity among adults with arthritis
| null |
%
|
Crude Prevalence
| 61.9
| 61.9
| null | null | 50.6
| 71.9
|
Age
|
Age 18-44
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
ART
|
ART06
| null |
CRDPREV
|
AGE
|
AGE1844
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
NVSS
|
Asthma
|
Asthma mortality among all people, underlying cause
| null |
Number
|
Number
| 37
| 37
| null | null | null | null |
Age
|
Age >=65
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
AST
|
AST01
| null |
NMBR
|
AGE
|
AGE65P
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
BRFSS
|
Chronic Obstructive Pulmonary Disease
|
Current smoking among adults with chronic obstructive pulmonary disease
| null |
%
|
Age-adjusted Prevalence
| null | null |
*
|
No data available
| null | null |
Race/Ethnicity
|
Asian, non-Hispanic
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
COPD
|
COPD02
| null |
AGEADJPREV
|
RACE
|
ASN
| null | null | null | null |
2,020
| 2,020
|
WV
|
West Virginia
|
BRFSS
|
Alcohol
|
Binge drinking frequency among adults who binge drink
| null |
Number
|
Crude Median
| null | null |
****
|
Data suppressed; denominator < 50 or relative standard error > 30%
| null | null |
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-80.71264013499967 38.66551020200046)
| 54
|
ALC
|
ALC04
| null |
CRDMEDN
|
RACE
|
HIS
| null | null | null | null |
2,019
| 2,019
|
AZ
|
Arizona
|
YRBSS
|
Sleep
|
Short sleep duration among high school students
| null |
%
|
Crude Prevalence
| 78.4
| 78.4
| null | null | 75
| 81.5
|
Sex
|
Male
| null | null | null | null |
POINT (-111.76381127699972 34.865970280000454)
| 4
|
SLEP
|
SLP02
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
AR
|
Arkansas
|
BRFSS
|
Arthritis
|
Arthritis among adults
| null |
%
|
Age-adjusted Prevalence
| 33.8
| 33.8
| null | null | 31.6
| 36.1
|
Sex
|
Female
| null | null | null | null |
POINT (-92.27449074299966 34.74865012400045)
| 5
|
ART
|
ART01
| null |
AGEADJPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
AR
|
Arkansas
|
BRFSS
|
Mental Health
|
Depression among adults
| null |
%
|
Crude Prevalence
| 27.8
| 27.8
| null | null | 24.7
| 31.1
|
Age
|
Age 18-44
| null | null | null | null |
POINT (-92.27449074299966 34.74865012400045)
| 5
|
MEN
|
MEN02
| null |
CRDPREV
|
AGE
|
AGE1844
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Alcohol
|
Binge drinking prevalence among adults
| null |
%
|
Age-adjusted Prevalence
| 20.8
| 20.8
| null | null | 18.9
| 22.9
|
Sex
|
Male
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
ALC
|
ALC06
| null |
AGEADJPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Arthritis
|
Physical inactivity among adults with arthritis
| null |
%
|
Age-adjusted Prevalence
| 26.9
| 26.9
| null | null | 22.3
| 32.1
|
Overall
|
Overall
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
ART
|
ART05
| null |
AGEADJPREV
|
OVERALL
|
OVR
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Arthritis
|
Received health care provider counseling for physical activity among adults with arthritis
| null |
%
|
Age-adjusted Prevalence
| 59.9
| 59.9
| null | null | 51.6
| 67.7
|
Sex
|
Male
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
ART
|
ART06
| null |
AGEADJPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Cardiovascular Disease
|
High cholesterol among adults who have been screened
| null |
%
|
Crude Prevalence
| 30
| 30
| null | null | 25.9
| 34.5
|
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
CVD
|
CVD03
| null |
CRDPREV
|
RACE
|
HIS
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Cardiovascular Disease
|
Taking medicine for high cholesterol among adults
| null |
%
|
Crude Prevalence
| 35.1
| 35.1
| null | null | 33.1
| 37.1
|
Sex
|
Male
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
CVD
|
CVD04
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
NVSS
|
Cardiovascular Disease
|
Cerebrovascular disease (stroke) mortality among all people, underlying cause
| null |
Number
|
Number
| 1,252
| 1,252
| null | null | null | null |
Age
|
Age >=65
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
CVD
|
CVD07
| null |
NMBR
|
AGE
|
AGE65P
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Immunization
|
Influenza vaccination among adults 18–64 who are at increased risk
| null |
%
|
Crude Prevalence
| 45.5
| 45.5
| null | null | 35.3
| 56.2
|
Race/Ethnicity
|
Black, non-Hispanic
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
IMM
|
IMM02
| null |
CRDPREV
|
RACE
|
BLK
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Immunization
|
Influenza vaccination among adults 18–64 who are at increased risk
| null |
%
|
Crude Prevalence
| 47.6
| 47.6
| null | null | 42.1
| 53.1
|
Sex
|
Male
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
IMM
|
IMM02
| null |
CRDPREV
|
SEX
|
SEXM
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Immunization
|
Pneumococcal vaccination among adults aged 65 years and older
| null |
%
|
Crude Prevalence
| 74.2
| 74.2
| null | null | 72.2
| 76.1
|
Overall
|
Overall
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
IMM
|
IMM04
| null |
CRDPREV
|
OVERALL
|
OVR
| null | null | null | null |
2,019
| 2,019
|
CT
|
Connecticut
|
BRFSS
|
Social Determinants of Health
|
Lack of health insurance among adults aged 18-64 years
| null |
%
|
Crude Prevalence
| 9.2
| 9.2
| null | null | 7.8
| 10.9
|
Sex
|
Female
| null | null | null | null |
POINT (-72.64984095199964 41.56266102000046)
| 9
|
SDOH
|
SDH09
| null |
CRDPREV
|
SEX
|
SEXF
| null | null | null | null |
2,019
| 2,019
|
DE
|
Delaware
|
BRFSS
|
Arthritis
|
Physical inactivity among adults with arthritis
| null |
%
|
Crude Prevalence
| null | null |
****
|
Data suppressed; denominator < 50 or relative standard error > 30%
| null | null |
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-75.57774116799965 39.008830667000495)
| 10
|
ART
|
ART05
| null |
CRDPREV
|
RACE
|
HIS
| null | null | null | null |
2,019
| 2,019
|
DE
|
Delaware
|
NVSS
|
Asthma
|
Asthma mortality among all people, underlying cause
| null |
cases per 100,000
|
Age-adjusted Rate
| null | null |
~
|
Data suppressed; too few respondents or cases
| null | null |
Race/Ethnicity
|
Hispanic
| null | null | null | null |
POINT (-75.57774116799965 39.008830667000495)
| 10
|
AST
|
AST01
| null |
AGEADJRATE
|
RACE
|
HIS
| null | null | null | null |
End of preview. Expand
in Data Studio
U.S. Chronic Disease Indicators
Description
CDC's Division of Population Health provides a cross-cutting set of 115 indicators developed by consensus among CDC, the Council of State and Territorial Epidemiologists, and the National Association of Chronic Disease Directors. These indicators allow states and territories to uniformly define, collect, and report chronic disease data that are important to public health practice in their area. In addition to providing access to state-specific indicator data, the CDI web site serves as a gateway to additional information and data resources.
Dataset Details
- Publisher: Centers for Disease Control and Prevention
- Last Modified: 2024-10-16
- Contact: CDC Info ([email protected])
Source
Original data can be found at: https://www.cdc.gov/cdi/overview.html
Usage
You can load this dataset using:
from datasets import load_dataset
dataset = load_dataset('HHS-Official/us-chronic-disease-indicators')
License
This dataset is licensed under http://opendatacommons.org/licenses/odbl/1.0/
- Downloads last month
- 86